Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals

BACKGROUND/OBJECTIVES: Frail participants are often under‐represented in randomized trials, raising questions about outcomes of interventions in real‐world settings. Frailty is strongly associated with vulnerability to illness and adverse health outcomes. We studied the impact of frailty on recombin...

Descripción completa

Detalles Bibliográficos
Autores principales: Curran, Desmond, Kim, Joon H., Matthews, Sean, Dessart, Christophe, Levin, Myron J., Oostvogels, Lidia, Riley, Megan E., Schmader, Kenneth E., Cunningham, Anthony L., McNeil, Shelly A., Schuind, Anne E., Andrew, Melissa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Regular Issue Content
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984267/
https://www.ncbi.nlm.nih.gov/pubmed/33197294
http://dx.doi.org/10.1111/jgs.16917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984267/
https://www.ncbi.nlm.nih.gov/pubmed/33197294
http://dx.doi.org/10.1111/jgs.16917

Ejemplares similares